Literature DB >> 24434843

Hyperuricemia is a significant risk factor for the onset of chronic kidney disease.

Akiko Toda1, Yuko Ishizaka, Mizuki Tani, Minoru Yamakado.   

Abstract

BACKGROUND: Recent studies have shown that hyperuricemia is an independent risk factor for cardiovascular disease. However, few studies have examined whether hyperuricemia is a risk factor for chronic kidney disease (CKD), so to investigate the significance of hyperuricemia as a risk factor for CKD, we analyzed data collected in annual health check-ups.
METHODS: The data of 11,048 subjects who underwent an annual health check-up were analyzed in cross-sectional and longitudinal studies.
RESULTS: After adjustment for covariate factors, a multivariate logistic regression analysis showed that age, systolic blood pressure, diastolic blood pressure, LDL-cholesterol, triglyceride, HbA1c, and uric acid (hazard ratio: 1.66) were independently and significantly associated with CKD. We also analyzed the data of 1,652 subjects who underwent annual health check-ups for 5 consecutive years. Over that 5-year period, 93 subjects developed CKD. We compared the baseline data of the subjects who developed CKD with the data of those who did not, and we found significant between-group differences in gender, age, HDL-cholesterol, the estimated glomerular filtration rate, and uric acid. After adjustment for several covariate factors, a multivariate Cox regression analysis showed that only age and hyperuricemia (hazard ratio: 1.36) were independent risk factors for the development of CKD.
CONCLUSIONS: We found that hyperuricemia is an independent risk factor for the development of CKD.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24434843     DOI: 10.1159/000355639

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  14 in total

Review 1.  An old disease with new insights: Update on diagnosis and treatment of gout.

Authors:  Berivan Bitik; M Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2014-06-01

2.  A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients.

Authors:  Masaki Ohya; Takashi Shigematsu
Journal:  Clin Exp Nephrol       Date:  2014-05-29       Impact factor: 2.801

3.  Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.

Authors:  Hakan Nacak; Merel van Diepen; Abdul R Qureshi; Juan J Carrero; Theo Stijnen; Friedo W Dekker; Marie Evans
Journal:  Nephrol Dial Transplant       Date:  2015-07-16       Impact factor: 5.992

4.  Influence of urate-lowering therapies on renal handling of uric acid.

Authors:  Lili Ma; Lei Wei; Huiyong Chen; Zhuojun Zhang; Qiang Yu; Zongfei Ji; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2014-11-06       Impact factor: 2.980

5.  Longitudinal changes in uric acid concentration and their relationship with chronic kidney disease progression in children and adolescents.

Authors:  George J Schwartz; Jennifer L Roem; Stephen R Hooper; Susan L Furth; Donald J Weaver; Bradley A Warady; Michael F Schneider
Journal:  Pediatr Nephrol       Date:  2022-06-01       Impact factor: 3.714

6.  Prediction of drug efficacy from transcriptional profiles with deep learning.

Authors:  Jie Zhu; Jingxiang Wang; Xin Wang; Mingjing Gao; Bingbing Guo; Miaomiao Gao; Jiarui Liu; Yanqiu Yu; Liang Wang; Weikaixin Kong; Yongpan An; Zurui Liu; Xinpei Sun; Zhuo Huang; Hong Zhou; Ning Zhang; Ruimao Zheng; Zhengwei Xie
Journal:  Nat Biotechnol       Date:  2021-06-17       Impact factor: 54.908

7.  The prevalence, subtypes and associated factors of hyperuricemia in lupus nephritis patients at chronic kidney disease stages 1-3.

Authors:  Simeng Liu; Yijun Gong; Hong Ren; Wen Zhang; Xiaonong Chen; Tong Zhou; Xiao Li; Nan Chen
Journal:  Oncotarget       Date:  2017-07-06

8.  The Effects of CYP2C19 genotype on the susceptibility for nephrosis in cardio-cerebral vascular disease treated by anticoagulation.

Authors:  Kai Chang; Zhongyong Jiang; Chenxia Liu; Junlong Ren; Ting Wang; Jie Xiong
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

9.  Efficacy of different urinary uric acid indicators in patients with chronic kidney disease.

Authors:  Haochen Guan; Yuqi Zheng; Xun Zhou; Ying Xu; Chensheng Fu; Jing Xiao; Zhibin Ye
Journal:  BMC Nephrol       Date:  2020-07-22       Impact factor: 2.388

10.  The Effects of Cardiometabolic Factors on the Association Between Serum Uric Acid and Chronic Kidney Disease in Chinese Middle-Aged and Older Population: A Mediation Analysis.

Authors:  Lu Xu; Hang Sun; Lili Liu; Siyan Zhan; Shengfeng Wang; Xiaozhen Lv; Yongfeng Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.